Used in research and therapeutic development targeting GPR73 (also known as PROKR1), this reference antibody serves as a critical tool for studying inflammatory and immune-related diseases. It enables precise detection and modulation of PROKR1 receptor activity, which is implicated in conditions such as asthma, atopic dermatitis, and other allergic disorders. Due to its high specificity, it supports target validation in preclinical studies and aids in the development of biologics aimed at blocking PROKR1 signaling pathways. The antibody is also utilized in pharmacokinetic and pharmacodynamic assays to assess drug candidates in development pipelines, particularly in immuno-oncology and chronic inflammation research. Its role in neutralizing receptor function makes it valuable for in vitro and in vivo models of disease where PROKR1-mediated signaling contributes to pathology.